Peer Review reports
From: A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers
| Original Submission | ||
|---|---|---|
| 6 Mar 2014 | Submitted | Original manuscript |
| 20 May 2014 | Reviewed | Reviewer Report - Jennifer Chan |
| 26 May 2014 | Reviewed | Reviewer Report - Michele Kim |
| 9 Jun 2014 | Author responded | Author comments - Daniel Halperin |
| Resubmission - Version 2 | ||
| 9 Jun 2014 | Submitted | Manuscript version 2 |
| 17 Jun 2014 | Reviewed | Reviewer Report - Jennifer Chan |
| 2 Jul 2014 | Reviewed | Reviewer Report - Michele Kim |
| 16 Jul 2014 | Author responded | Author comments - Daniel Halperin |
| Resubmission - Version 3 | ||
| 16 Jul 2014 | Submitted | Manuscript version 3 |
| Publishing | ||
| 22 Jul 2014 | Editorially accepted | |
| 2 Aug 2014 | Article published | 10.1186/1471-2407-14-561 |
You can find further information about peer review here.